New way to deliver chemo may boost survival in stomach cancer patients
Disease control
Recruiting now
This phase 3 trial tests whether giving chemotherapy directly into the abdomen (intraperitoneal paclitaxel) along with standard systemic therapy improves survival compared to systemic therapy alone in stomach cancer patients whose cancer has spread to the lining of the abdomen. A…
Phase: PHASE3 • Sponsor: Magnus Nilsson • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC